A new study offers insights into the relative efficacy of various treatments for alopecia areata (AA), suggesting that ...

Alopecia areata, an autoimmune disorder causing hair loss, now has an FDA-approved treatment since June 2022. While some explore home remedies like essential oils, dietary changes, and stress ...

Leqselvi (deuruxolitinib) 8 mg tablets are approved for adults with severe alopecia areata, a disease that causes the immune ...

The stigma of having alopecia causes more depression and anxiety than the disease itself, new research has found.

Patients with higher-severity alopecia areata (AA) have a higher prevalence and incidence of comorbid atopic dermatitis (AD), ...

The stigma of having alopecia causes more depression and anxiety than the disease itself, new research has found.

Combined Company to Trade on Nasdaq Under Ticker "IMA" Ikena Announces 1-for-12 Reverse Stock Split of Ikena Common Stock BOSTON and SAN DIEGO, July 15, 2025 (GLOBE NEWSWIRE) -- Ikena Oncology, Inc.

New Drug Submission meeting scheduled with Health Canada for the third quarter of 2025Initial briefing book submitted for review to the European Medicines Agency WARREN, N.J., July 15, 2025 (GLOBE NEW ...

Leqselvi ™ (deuruxolitinib) is now available for the treatment of adults with severe alopecia areata.

10 Charts to Explain What’s Shaping the Ag Economy to Start 2025 From tariffs and trade to the possible impact of President Donald Trump’s plan to cut regulations and taxes, ag economists ...